Creatine Supplementation During GLP-1a Therapy (NCT07625202)
A Pilot Study on Creatine Supplementation During Resistance-training for Prevention of Lean Tissue Mass Loss During GLP-1 Receptor Agonist Therapy
🩺 Plain-English Summary (8th-Grade Level)
GLP-1 receptor agonists are effective for weight loss, but significant muscle mass is lost as a proportion of this weight loss. This study combines resistance-training and creatine supplementation to try to prevent this loss of muscle mass.
Who can join: Review the eligibility criteria below.
Location: University of Saskatchewan — Saskatoon, SK - Saskatchewan
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Saskatchewan — Saskatoon, SK - Saskatchewan
📞 Contact the Study Coordinator
Phone: (306) 966-1072
Email: phil.chilibeck@usask.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Sarcopenia
- Impacts of Nicotinamide Riboside on Functional Capacity and Muscle Physiology in Older Veterans — Kansas City, Missouri
- Muscle Impact of Treating Osteoporosis — Pittsburgh, Pennsylvania
- Effects of Polyphenol Supplementation and Exercise on Physical Performance in Older Adults — Kingston, Ontario
- Electrical Stimulation of Human Myocytes in Microgravity — Orlando, Florida
- BandPass: A Remote Monitoring System for Sarcopenia and Functional Decline Phase II Aim 4 — Chapel Hill, North Carolina
- Validation of a Body-Composition Segmentation Software on a Diverse Public CT Scan Cohort — San Francisco, California
Explore by condition: All Sarcopenia clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.